Heather White
Technik-/Wissenschafts-/F&E-Leiter bei ALBIREO PHARMA, INC.
Aktive Positionen von Heather White
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.03.2023 | - |
Karriereverlauf von Heather White
Ehemalige bekannte Positionen von Heather White
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMICUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 | - |
| IPSEN | Comptroller/Controller/Auditor | 01.01.2014 | - |
Ausbildung von Heather White
| The University of Liverpool | Graduate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 3 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IPSEN | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Schering-Plough Ltd.
Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Heather White
- Erfahrung
